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inTRODUCTiOn
Multiple sclerosis (MS) is a neurodegenerative disorder characterized by an inflammatory autoim-
mune disease process in the central nervous system (CNS) (1). MS presents with clinical impair-
ments based on location and severity of CNS lesions. Fatigue is the most common reported symptom 
of people with MS (PwMS) (2), and 80–85% of individuals describe it as the most disabling feature of 
the disease (3, 4). Decreased quality of life (5), limited physical activity (6, 7), and increased rates of 
depression and anxiety (8, 9) are associated with higher levels of reported fatigue among PwMS. The 
specific etiology of fatigue in MS is unknown, and it is likely the product of multiple factors rather 
than a single cause (1).
There is a need for development of a unified taxonomy to help define what people experience when 
they report fatigue (10, 11). An early attempt to define fatigue was published from the 1981 CIBA 
Foundation Symposium in “Human Muscle Fatigue: Physiological Mechanisms” by Edwards (12) as 
“a failure to maintain the required or expected force.” While Edwards provided a simple and direct 
operational definition, it failed to convey subjective feelings described by PwMS. Enoka and Stuart 
(13) expanded Edwards’ definition to include perception, stating that fatigue is “an acute impairment 
of performance that includes both an increase in the perceived effort necessary to exert a desired 
force and the eventual inability to produce this force.” This definition features Mosso’s dichotomy and 
is now a commonly used framework within the realm of fatigue research (13). Within this taxonomy, 
force decrements are considered distinct from sensations that arise from prolonged muscular activ-
ity. However, as investigators began to uncover multiple mechanistic causes for fatigue, they began to 
label fatigue with descriptors consisting of the independent variables studied. Examples of this trend 
include cognitive fatigue, peripheral fatigue, and central fatigue among others. Beyond cohesive 
operational definitions, the limited ability to isolate components of Enoka and Stuart’s expanded 
definition explains, in part, why so little progress has been made in addressing clinically reported 
fatigue symptoms (14).
Kluger et al. (10) presented a taxonomy that attempts to reunite the developing silos of fatigue 
work by returning to Enoka and Stuart’s definition. He calls for the common language of fatigue to 
be divided into two well-defined categories, distinguishing between the perception of fatigue and 
fatigability. “Perception of fatigue” defines subjective sensations related to an individual’s symptom 
complaint and is the result of homeostatic and psychological factors. “Fatigability” relates to task 
performance and is defined by a change in performance relative to an objective criterion. Enoka 
and Duchateau (11) presented additional framework for viewing fatigue as a symptom that has a 
trait characteristic and can be influenced by state variables. This view of fatigue allows researchers to 
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measure the effects of short-term and modifiable state variables 
on the long-term trait characteristic of fatigue (i.e., the perception 
of fatigue or fatigability). The approach of Enoka and Duchateau 
(11) encourages investigators to emphasize their assessment 
methodology and the task dependency of fatigue, while mini-
mizing use of obtuse modifiers or descriptors that lack clarity 
and yield little insight into causative factors. Developing and 
conceptualizing unified operational definitions of fatigue holds 
ramifications for clinical practice. It is our view that a combina-
tion of poorly defined taxonomies, unknown etiology, and vague 
clinical descriptions have made fatigue difficult to quantify dur-
ing clinical assessment. Therefore, it is not surprising that current 
treatments are non-specific and yield unsatisfactory outcomes.
The purpose of this paper is to convey the limitations of current 
fatigue assessments for evaluating task performance fatigability 
in rehabilitative settings for PwMS. Additionally, we call for the 
development of clinical tests which can measure the influence of 
state variables on the trait characteristic of performance fatigabil-
ity as it relates to function and quality of life.
THE LiMiTATiOnS OF SUBJECTiVE 
ASSESSMEnT in CLiniCAL 
REHABiLiTATiOn EnViROnMEnTS
The fatigue severity scale (FSS) and fatigue impact scale (FIS) are 
questionnaires of self-reported fatigue. Both tests are the current 
primary clinical outcome measures for objectively measuring 
fatigue symptoms in MS. For example, Latimer-Cheung et  al. 
(15) examined over 30 studies where at least one of these ques-
tionnaires was the primary outcome for measuring the impact 
of exercise on fatigue. While self-reported fatigue remains an 
important outcome, the use of the FSS and FIS involves limita-
tions associated with questionnaires regarding regression to the 
mean and response bias (16). Moreover, exercise-based interven-
tions paradoxically show large changes in functional capacity 
and independence with only mild to moderate changes in fatigue 
questionnaire scores after skilled physical therapy including aero-
bic endurance training and progressive resistance training (17, 
18). Scores on both the FSS and FIS correlate with disease severity 
as determined by the extended disability status scale (EDSS) in 
PwMS (19). However, the FSS and FIS do not adequately reflect 
functional status established by clinical outcome measures such 
as the 6-min walk test (20, 21), gait speed, or temporal and spatial 
components of gait kinematics (22). Questionnaires may have 
poor association with indices of whole muscle fatigue derived 
from isometric muscle testing (18). The utility of self-reported 
fatigue assessments may be constrained by the confounding of 
qualitative complaints of fatigue by other MS impairments (23). 
Steens et al. (24) found fatigability in PwMS explained variance 
in FSS scores; however, more of the variance was explained when 
adding depression to the regression. This exemplifies how a quali-
tative complaint or perception can influence subjective tests and 
highlights the need for developing objective measures of fatiga-
bility. In our opinion, the need for outcome measures to separate 
fatigability from the perception of fatigue is critical in clinical 
practice environments such as rehabilitative medicine. Clinically 
measuring fatigability requires careful consideration to develop 
appropriate performance tasks and valid outcomes (10). Based 
on this perspective, emphasis needs to be placed on developing 
clinical assessments correlated with state variables of fatigability 
to accurately evaluate the trait characteristic of fatigue’s influence 
on an individual’s function, when determining independence or 
recovery in PwMS.
EnHAnCinG FUnCTiOnAL OUTCOMES 
WiTH CLiniCAL FATiGABiLiTY 
ASSESSMEnT
Historically, PwMS were discouraged from participating in 
regular exercise to avoid exacerbating fatigue (25). There has 
been a paradigm shift in the last decade as exercise programs 
for PwMS have demonstrated promising improvements in func-
tional performance (26). A growing body of evidence suggests 
that rehabilitative programs for PwMS may enhance quality of 
life and contribute to maintaining independence throughout 
the progression of the disease. Several interventions including a 
resistance-training component, in particular, may be effective for 
reducing both perceived fatigue and improving functional status 
(15, 26). However, there is a lack of consensus on the most effica-
cious exercise modality and dosage for treating reported fatigue 
in PwMS. Furthermore, it is the authors’ view that the failure to 
include fatigability measures as the primary outcome in exercise 
studies limits the ability to draw firm conclusions regarding the 
efficacy of an exercise prescription on modifying state variables 
related to performance fatigability in PwMS. This omission may 
partially explain the limited adoption of strength training and 
other modes of exercise as viable treatment options for fatigability 
in PwMS (26).
Reframing how investigators characterize fatigue in MS may 
guide subsequent research efforts within this area of inquiry. 
Enoka and Duchateau (11) have proposed three levels of analysis 
for measuring the impact of fatigability on human performance. 
They propose first selecting a criterion measure of performance 
modulated by fatigue and then identifying a laboratory test that 
measures the performance of the criterion measure. Finally, 
they suggest conducting studies to determine the significance 
of adjustments to the modulating factors limiting performance 
on the laboratory test (where the modulating factors are state 
variables, and the reported symptom of fatigue relates to the trait 
characteristic of the individual). In Figure 1, the authors present 
a similar strategy that can be adopted for clinical measurement 
as well.
In a rehabilitative setting, clinical assessments of fatigability 
should be associated with functional tasks of daily living. Steens 
et al. (24, 27) have begun to look at state characteristics of fatiga-
bility, including muscular strength and capacity (both criterion 
measures of performance), which are associated with trait levels 
of fatigue reported in PwMS. While it is helpful to understand 
that state variables of fatigability relate to the overall trait of 
fatigue, we still have limited knowledge about how these variables 
are associated with clinical assessment measures. For example, 
Steens’ observations did not include limb muscles that are more 
FiGURE 1 | Hierarchy chart depicting the general steps for 
associating clinical assessments of fatigability with overall fatigue in 
individuals with MS. Self-reported measures of perceived fatigue do not 
consistently correspond to performance-based measures of fatigability. Valid 
functional measures of fatigue must be associated with accepted estimates 
of fatigability and viable for use in rehabilitation settings. Better understanding 
of the relationship between the performance-based criterion measures and 
the trait characteristic of fatigability may aid our approach to the assessment 
and treatment of those people with multiple sclerosis. Notes: *Examples of 
criterion measures include the duration of task sustainability, rate of change in 
force production, power, voluntary activation, reaction times, heart rate, mean 
arterial pressure, core temperature, and outcomes of muscle morphology. 
†Examples of functional performance tests include the Adult Myopathy 
Assessment Test (AMAT), Short Physical Performance Battery Protocol 
(SPPB), and Dalgas’ Functional Capacity Test (FCT). ‡Examples of state 
variables include the exercise prescription, modality of exercise, and exercise 
environment. §Examples of intervention to manipulate a state variable: a 
progressive resistance exercise program or an aerobic endurance exercise 
program.
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likely to mimic functional task requirements and mobility in MS. 
Little is known about the relationship between state variables of 
MS-related fatigue and the performance of limb musculature 
involved in tasks such as walking, which is heavily evaluated as a 
functional outcome related to independence in this population.
Our stance is that the development of clinical assessments, 
which manipulate state variables under fatiguing tasks, is the 
most direct way to evaluate the trait characteristic of fatigue on 
functional performance. Of key importance is designing tests 
which can best mimic functional requirements of daily living. 
Current functional exams of performance in MS are not strongly 
associated with fatigue as a trait characteristic (20–22). Tests 
which may hold promise include the Short Physical Performance 
Battery Protocol (28), Adult Myopathy Assessment Tool (29), 
and the Functional Capacity Test developed by Dalgas et al. (30). 
These tests attempt to combine various repetitive tasks which 
mimic daily function. However, it is our opinion that the validity 
of these tests would be enhanced by better understanding their 
association with trait characteristics of fatigue. The construct 
validity of the aforementioned tests would be strengthened by 
determining the relationship between the scores obtained from 
these functional assessments and performance values from 
various fatigue tests in both aerobic and anaerobic conditions. 
This approach would better characterize how state variables 
such as metabolic requirements or muscle actions would align 
with task specificity measured within a clinic. Dalgas et al. (31) 
state that limited existing literature on fatigability responses in 
aerobic compared to anaerobic environments has made assess-
ment of both endurance and strength exercise trials difficult. 
Another outcome often overlooked when evaluating state vari-
ables of muscle performance is anaerobic recovery. Our view is 
that further inquiry into anaerobic recovery relative to muscle 
capacity could provide meaningful insights into how fatigability 
affects temporal aspects of functional task performance. Such 
information could help practitioners adjust exercise prescription 
and monitor training adaptations.
Assessment of muscle morphology as a state variable may also 
provide valuable insights concerning performance fatigability. 
Previous work by Kent-Braun et  al. (32) and Wens et  al. (33) 
highlight changes in muscle related to cross-sectional area, size, 
composition, and fiber type in PwMS. Importantly, diminished 
muscle cross-sectional area and greater levels of intramuscular 
adipose tissue are associated with poor performance with repeated 
or sustained functional tasks (34). While methods to character-
ize skeletal muscle are often invasive or difficult to implement in 
rehabilitation settings (32, 35), alternative approaches involving 
ultrasound have shown that proxy measures of muscle tissue 
composition are also associated with impaired performance (36, 
37). Further study regarding muscle morphology using clinically 
viable methods may advance our understanding of the state vari-
ables of fatigability in MS.
Further evaluation of the impact of modulating state variables 
on fatigability in clinical rehabilitation settings will be challeng-
ing. The current trend of measuring multiple state variables of 
fatigue at once has masked the clinically significant changes 
that can occur through interventions (15). However, building a 
consensus regarding a unified fatigue taxonomy, and the further 
development of standardized methods to assess state variables of 
fatigability, will advance the larger goal of implementing effective 
rehabilitation treatment for MS-related fatigue.
COnCLUSiOn
Fatigue is a vague symptom that defies simple characterization. 
Due to this ambiguity, there is a need for quantifiable clinical 
measures of performance fatigability as they relate to the reha-
bilitation of PwMS. Assessing fatigability may be critical for 
understanding the relationship between an individual’s function 
and reported fatigue symptoms. Performance-based fatigability 
testing provides an in-depth view of muscle function as a state 
variable related to activities of daily living and mobility. With 
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focused clinical testing, rehabilitation professionals can track the 
response to interventions and make recommendations on specific 
exercise prescriptions for PwMS. Taking these steps will help cli-
nicians guide PwMS toward the goals of minimizing debilitating 
fatigue, improving functional performance, and enhancing their 
quality of life.
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